SECURITIES AND EXCHANGE COMMISSION
FORM 10-Q
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 29, 2003
Commission file number 000-49602
SYNAPTICS INCORPORATED
Delaware | 77-0118518 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
2381 Bering Drive
San Jose, California 95131
(408) 434-0110
Indicate by check whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
Number of shares of Common Stock outstanding at May 6, 2003: 23,579,735
SYNAPTICS INCORPORATED
QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTER ENDED MARCH 31, 2003
TABLE OF CONTENTS
Page | ||||||
Part I. Financial Information |
||||||
Item 1. Financial Statements: |
||||||
Condensed Consolidated Balance Sheets March 31, 2003 and June 30, 2002 (Unaudited) |
3 | |||||
Condensed Consolidated Statements of Operations Three Months and Nine Months Ended March 31, 2003 and 2002 (Unaudited) |
4 | |||||
Condensed Consolidated Statements of Cash Flows Nine Months Ended March 31, 2003 and 2002 (Unaudited) |
5 | |||||
Notes to Condensed Consolidated Financial Statements (Unaudited) |
6 | |||||
Item 2. Managements Discussion and Analysis of Financial
Condition and Results of Operations |
11 | |||||
Item 3. Quantitative and Qualitative Disclosures About Market Risk |
16 | |||||
Item 4. Controls and Procedures |
16 | |||||
Part II. Other Information |
||||||
Item 6. Exhibits and Reports on Form 8-K |
17 | |||||
Signatures |
18 | |||||
Certifications |
19 |
PART I FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
SYNAPTICS INCORPORATED
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
March 31, | June 30, | |||||||||||
2003 | 2002 (1) | |||||||||||
(unaudited) | ||||||||||||
ASSETS | ||||||||||||
Current assets: |
||||||||||||
Cash and cash equivalents |
$ | 38,584 | $ | 45,491 | ||||||||
Short-term investments |
34,314 | 19,689 | ||||||||||
Accounts receivable, net of allowances of $210 and $200
at March 31, 2003 and June 30, 2002, respectively |
14,152 | 13,242 | ||||||||||
Inventories |
5,782 | 5,867 | ||||||||||
Prepaid expenses and other current assets |
3,745 | 2,964 | ||||||||||
Total current assets |
96,577 | 87,253 | ||||||||||
Property and equipment, net |
1,870 | 2,043 | ||||||||||
Goodwill |
765 | 765 | ||||||||||
Other assets |
270 | 320 | ||||||||||
Total assets |
$ | 99,482 | $ | 90,381 | ||||||||
LIABILITIES AND STOCKHOLDERS EQUITY | ||||||||||||
Current liabilities: |
||||||||||||
Accounts payable |
$ | 6,806 | $ | 5,867 | ||||||||
Accrued compensation |
2,383 | 2,161 | ||||||||||
Accrued warranty |
1,002 | 1,002 | ||||||||||
Income taxes payable |
3,050 | 2,646 | ||||||||||
Other accrued liabilities |
2,343 | 1,814 | ||||||||||
Capital leases and equipment financing obligations |
286 | 445 | ||||||||||
Total current liabilities |
15,870 | 13,935 | ||||||||||
Capital leases and equipment financing obligations, net of
current portion |
55 | 259 | ||||||||||
Note payable to a related party |
1,500 | 1,500 | ||||||||||
Other liabilities |
741 | 684 | ||||||||||
Commitments and contingencies |
||||||||||||
Stockholders equity: |
||||||||||||
Common stock; $0.001 par value; 60,000,000 shares authorized; 23,567,455 and 23,182,757 shares issued and outstanding as of March 31, 2003 and June 30, 2002, respectively |
24 | 23 | ||||||||||
Additional paid-in capital |
77,294 | 75,013 | ||||||||||
Deferred stock compensation |
(1,339 | ) | (1,085 | ) | ||||||||
Notes receivable from stockholders |
(755 | ) | (876 | ) | ||||||||
Retained earnings |
5,979 | 865 | ||||||||||
Accumulated other comprehensive income |
113 | 63 | ||||||||||
Total stockholders equity |
81,316 | 74,003 | ||||||||||
Total liabilities and stockholders equity |
$ | 99,482 | $ | 90,381 | ||||||||
(1) | Derived from our audited financial statements as of June 30, 2002, included in our Form 10-K filed with the Securities and Exchange Commission. |
See notes to condensed consolidated financial statements.
3
SYNAPTICS INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)
Three Months Ended | Nine Months Ended | ||||||||||||||||
March 31, | March 31, | ||||||||||||||||
2003 | 2002 | 2003 | 2002 | ||||||||||||||
Net revenue |
$ | 26,103 | $ | 24,421 | $ | 72,479 | $ | 74,392 | |||||||||
Cost of revenue (1) |
15,385 | 14,197 | 41,745 | 44,180 | |||||||||||||
Gross margin |
10,718 | 10,224 | 30,734 | 30,212 | |||||||||||||
Operating expenses: |
|||||||||||||||||
Research and development (1) |
4,942 | 4,072 | 15,077 | 11,880 | |||||||||||||
Selling, general, and administrative (1) |
2,715 | 2,351 | 7,957 | 7,451 | |||||||||||||
Amortization of other acquired
intangible assets |
| 29 | 40 | 104 | |||||||||||||
Amortization of deferred stock
compensation |
137 | 121 | 363 | 363 | |||||||||||||
Total operating expenses |
7,794 | 6,573 | 23,437 | 19,798 | |||||||||||||
Operating income |
2,924 | 3,651 | 7,297 | 10,414 | |||||||||||||
Interest income |
259 | 151 | 815 | 232 | |||||||||||||
Interest expense |
(35 | ) | (43 | ) | (121 | ) | (156 | ) | |||||||||
Income before provision for income taxes |
3,148 | 3,759 | 7,991 | 10,490 | |||||||||||||
Provision for income taxes |
1,079 | 1,321 | 2,877 | 3,663 | |||||||||||||
Net income |
$ | 2,069 | $ | 2,438 | $ | 5,114 | $ | 6,827 | |||||||||
Net income per share: |
|||||||||||||||||
Basic |
$ | 0.09 | $ | 0.14 | $ | 0.22 | $ | 0.66 | |||||||||
Diluted |
$ | 0.08 | $ | 0.10 | $ | 0.21 | $ | 0.31 | |||||||||
Shares used in computing net income
per share: |
|||||||||||||||||
Basic |
23,537 | 17,653 | 23,407 | 10,329 | |||||||||||||
Diluted |
25,125 | 24,422 | 24,869 | 21,720 | |||||||||||||
(1) | Cost of revenue excludes $7,000, $7,000, $21,000, and $21,000 of amortization of deferred stock compensation for the three months ended March 31, 2003 and 2002, and the nine months ended March 31, 2003 and 2002, respectively. Research and development expense excludes $38,000, $49,000, $115,000, and $147,000 of amortization of deferred stock compensation for the three months ended March 31, 2003 and 2002, and the nine months ended March 31, 2003 and 2002, respectively. Selling, general, and administrative expenses exclude $92,000, $65,000, $227,000, and $195,000 of amortization of deferred stock compensation for the three months ended March 31, 2003 and 2002, and the nine months ended March 31, 2003 and 2002, respectively. These amounts have been aggregated and reflected as Amortization of deferred stock compensation. |
See notes to condensed consolidated financial statements.
4
SYNAPTICS INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
Nine Months Ended | ||||||||||
March 31, | ||||||||||
2003 | 2002 | |||||||||
Operating activities |
||||||||||
Net income |
$ | 5,114 | $ | 6,827 | ||||||
Adjustments to reconcile net income to net cash provided by operating
activities: |
||||||||||
Depreciation and amortization of property and equipment |
1,071 | 883 | ||||||||
Amortization of other acquired intangible assets |
40 | 104 | ||||||||
Amortization of deferred stock compensation |
363 | 363 | ||||||||
Fair value of options issued to consultants for services rendered |
17 | | ||||||||
Changes in operating assets and liabilities: |
||||||||||
Accounts receivable |
(910 | ) | (1,470 | ) | ||||||
Inventories |
85 | 632 | ||||||||
Prepaid expenses and other current assets |
(781 | ) | (783 | ) | ||||||
Other assets |
10 | 262 | ||||||||
Accounts payable |
939 | 541 | ||||||||
Accrued compensation and warranty |
222 | 711 | ||||||||
Other accrued liabilities and income taxes payable |
933 | 1,364 | ||||||||
Other liabilities |
57 | 67 | ||||||||
Net cash provided by operating activities |
7,160 | 9,501 | ||||||||
Investing activities |
||||||||||
Purchases of short-term investments |
(18,144 | ) | (6,715 | ) | ||||||
Proceeds from sales and maturities of short-term investments |
3,569 | | ||||||||
Purchase of property and equipment |
(898 | ) | (1,103 | ) | ||||||
Net cash used in investing activities |
(15,473 | ) | (7,818 | ) | ||||||
Financing activities |
||||||||||
Payments on capital leases and equipment financing obligations |
(363 | ) | (339 | ) | ||||||
Proceeds from equipment financing |
| 308 | ||||||||
Proceeds from issuance of common stock upon initial public offering
net of issuance costs |
| 49,290 | ||||||||
Proceeds from issuance of common stock under ESPP and stock option
plans |
1,648 | 788 | ||||||||
Repayment of notes receivable from stockholders |
121 | 30 | ||||||||
Net cash provided by financing activities |
1,406 | 50,077 | ||||||||
(Decrease) Increase in cash and cash equivalents |
(6,907 | ) | 51,760 | |||||||
Cash and cash equivalents at beginning of period |
45,491 | 3,766 | ||||||||
Cash and cash equivalents at end of period |
$ | 38,584 | $ | 55,526 | ||||||
Supplemental disclosures of cash flow information |
||||||||||
Cash paid for interest |
22 | 73 | ||||||||
Cash paid for income taxes |
2,442 | 2,313 | ||||||||
Issuance of common stock from escrow related to the acquisition of
sales representative workforce |
| 75 | ||||||||
Unrealized gain/(loss) on short term investments |
50 | (5 | ) |
See notes to condensed consolidated financial statements.
5
SYNAPTICS INCORPORATED
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
1. Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission and generally accepted accounting principles. However, certain information or footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. In our opinion, the statements include all adjustments, which are of a normal and recurring nature, necessary for the fair presentation of the results of the interim periods presented. The results of operations for the interim periods are not necessarily indicative of the operating results for the full fiscal year or any future period. These financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in our annual report on Form 10-K for the year ended June 30, 2002.
The condensed consolidated financial statements include our financial statements and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated upon consolidation.
Our fiscal year ends on the last Saturday in June. For ease of presentation, the accompanying condensed consolidated financial statements have been shown as ending on June 30 and calendar quarter ends for all annual, interim, and quarterly financial statement captions.
We have elected to follow APB Opinion 25, Accounting for Stock Issued to Employees, and related interpretations in accounting for stock options. Had compensation expense for stock options been determined based on the fair value of the option at date of grant consistent with the provisions of FAS No. 123, Accounting for Stock-Based Compensation, net income and earnings per share would have been reduced to the pro forma amounts indicated below (in thousands, except per share amounts):
Three Months Ended | Nine Months Ended | |||||||||||||||||
March 31, | March 31, | |||||||||||||||||
2003 | 2002 | 2003 | 2002 | |||||||||||||||
Net income as reported |
$ | 2,069 | $ | 2,438 | $ | 5,114 | $ | 6,827 | ||||||||||
Stock-based compensation |
137 | 121 | 363 | 363 | ||||||||||||||
Total stock-based
compensation determined
under fair value based
method for all awards |
(778 | ) | (553 | ) | (2,018 | ) | (1,487 | ) | ||||||||||
Adjusted net income, fair
value method for all
stock-based awards |
$ | 1,428 | $ | 2,006 | $ | 3,459 | $ | 5,703 | ||||||||||
Net income per share Basic: |
||||||||||||||||||
As reported |
$ | 0.09 | $ | 0.14 | $ | 0.22 | $ | 0.66 | ||||||||||
SFAS No. 123 adjusted |
$ | 0.06 | $ | 0.11 | $ | 0.15 | $ | 0.55 | ||||||||||
Net income per share Diluted: |
||||||||||||||||||
As reported |
$ | 0.08 | $ | 0.10 | $ | 0.21 | $ | 0.31 | ||||||||||
SFAS No. 123 adjusted |
$ | 0.06 | $ | 0.08 | $ | 0.14 | $ | 0.26 |
The fair value of each award granted was estimated at the date of grant using a Black-Scholes option-pricing model, assuming no expected dividends and the following weighted average assumptions.
Options | ESPP | |||||||||||||||
Three Months Ended | Three Months Ended | |||||||||||||||
March 31, | March 31, | |||||||||||||||
2003 | 2002 | 2003 | 2002 | |||||||||||||
Expected annual volatility |
84.5 | % | 84.5 | % | 84.5 | % | 84.5 | % | ||||||||
Expected life of options in years |
5 | 5 | .4 | .4 | ||||||||||||
Risk-free interest rate |
2.8 | % | 4.8 | % | 1.1 | % | 2.0 | % | ||||||||
Expected dividend yield |
0 | 0 | 0 | 0 |
6
Options | ESPP | |||||||||||||||
Nine Months Ended | Nine Months Ended | |||||||||||||||
March 31, | March 31, | |||||||||||||||
2003 | 2002 | 2003 | 2002 | |||||||||||||
Expected annual volatility |
84.5% | % | 84.5 | % | 84.5 | % | 84.5 | % | ||||||||
Expected life of options in years |
5 | 5 | .4 | .4 | ||||||||||||
Risk-free interest rate |
2.8 | % | 4.8 | % | 1.1 | % | 2.0 | % | ||||||||
Expected dividend yield |
0 | 0 | 0 | 0 |
2. Revenue Recognition
We recognize revenue from product sales when there is persuasive evidence that an arrangement exists, delivery has occurred and title has transferred, the price is fixed and determinable, and collectibility is reasonably assured. We accrue for estimated sales returns and other allowances at the time of recognition of revenue, which is typically upon shipment, based on historical experience. Contract revenue for research and development is recorded as earned based on the performance requirements of the contract. Non-refundable contract fees for which no further performance obligations exist, and for which there is no continuing involvement by us, are recognized on the earlier of when the payments are received or when collection is assured.
3. Net Income Per Share
Basic net income per share amounts have been computed using the weighted-average number of shares of common stock outstanding during each period, less shares subject to repurchase. Diluted net income per share amounts also include the effect of potentially dilutive securities, including stock options, warrants, and convertible preferred stock, when dilutive.
The following table presents the computation of basic and diluted net income per share (in thousands, except per share amounts):
Three Months Ended | Nine Months Ended | |||||||||||||||||
March 31, | March 31, | |||||||||||||||||
2003 | 2002 | 2003 | 2002 | |||||||||||||||
Numerator for basic and diluted net income per
share: |
||||||||||||||||||
Net income |
$ | 2,069 | $ | 2,438 | $ | 5,114 | $ | 6,827 | ||||||||||
Denominator for basic net income per share: |
||||||||||||||||||
Weighted average common shares outstanding |
23,537 | 17,653 | 23,407 | 10,337 | ||||||||||||||
Less: Weighted average shares subject to
repurchase |
| | | (8 | ) | |||||||||||||
Denominator for basic net income per share |
23,537 | 17,653 | 23,407 | 10,329 | ||||||||||||||
Denominator for diluted net income per share: |
||||||||||||||||||
Shares used above, basic |
23,537 | 17,653 | 23,407 | 10,329 | ||||||||||||||
Dilutive stock options |
1,588 | 2,978 | 1,462 | 2,705 | ||||||||||||||
Dilutive warrants |
| 8 | | 17 | ||||||||||||||
Dilutive preferred stock |
| 3,772 | | 8,640 | ||||||||||||||
Dilutive contingent shares |
| 11 | | 29 | ||||||||||||||
Denominator for diluted net income per share |
25,125 | 24,422 | 24,869 | 21,720 | ||||||||||||||
Net income per share: |
||||||||||||||||||
Basic |
$ | 0.09 | $ | 0.14 | $ | 0.22 | $ | 0.66 | ||||||||||
Diluted |
$ | 0.08 | $ | 0.10 | $ | 0.21 | $ | 0.31 | ||||||||||
7
4. Cash Equivalents and Short-term Investments
Cash equivalents consist of highly liquid investments with original maturities of three months or less. Short-term investments consist of debt securities classified as available for sale and are carried at their fair value as of the balance sheet date. The amortized cost of securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization is included in interest income. Realized gains or losses are determined on the specific identification method and are reflected in interest income. Net unrealized gains or losses are recorded directly in stockholders equity except for unrealized losses that are deemed to be other than temporary, which are reflected in income.
5. Comprehensive Income
Comprehensive income includes all changes in stockholders equity during a period except those resulting from investments by owners and distributions to owners. Other comprehensive income comprises unrealized gains and losses on available-for-sale securities. The changes in the components of comprehensive income were as follows (in thousands):
Three Months Ended | Nine Months Ended | |||||||||||||||
March 31, | March 31, | |||||||||||||||
2003 | 2002 | 2003 | 2002 | |||||||||||||
Net income |
$ | 2,069 | $ | 2,438 | $ | 5,114 | $ | 6,827 | ||||||||
Net unrealized gains/(losses) on
available for sale securities |
(34 | ) | (5 | ) | 50 | (5 | ) | |||||||||
Other comprehensive income |
$ | 2,035 | $ | 2,433 | $ | 5,164 | $ | 6,822 | ||||||||
6. Inventories
Inventories are stated at the lower of cost (first-in, first-out method) or market (estimated net realizable value) and consisted of the following (in thousands):
March 31, | June 30, | |||||||
2003 | 2002 | |||||||
Raw materials |
$ | 3,738 | $ | 4,136 | ||||
Work-in-process |
$ | 1,757 | $ | 1,554 | ||||
Finished goods |
287 | 177 | ||||||
$ | 5,782 | $ | 5,867 | |||||
7. Accrued Warranty
We generally warrant our products for a period of 12 months from the date of sale and estimate probable product warranty costs at the time revenue is recognized. Factors that affect our warranty liability include historical and anticipated rates of warranty claims, material usage, and service delivery costs. Warranty costs incurred have not been material in recent years. However, we assess the adequacy of our warranty obligations periodically and adjust the accrued warranty liability on the basis of our estimates.
8
Changes in our warranty liability during the period are as follows (in thousands):
Balance at June 30, 2002 |
$ | 1,002 | ||
Warranties issued during the period |
37 | |||
Settlements made during the period |
(37 | ) | ||
Changes in liability for pre-existing warranties during
the period, including expirations |
| |||
Balance at March 31, 2003 |
$ | 1,002 | ||
8. Income Taxes
The income tax provision for the three-month and nine-month periods ended March 31, 2003 reflects an effective income tax rate based on expected pre-tax income for the year. The difference between the federal statutory rate of 35% and our effective tax rate of 36% for the nine months ended March 31, 2003 is primarily due to state taxes, expected research and development credits, and federal tax-exempt investments.
9. Segment, Customers, and Geographic Information
We operate in one segment, the development, marketing, and sale of interactive user interface solutions for intelligent electronic devices and products, and currently generate our revenue primarily from companies in the personal computer (PC) market.
The following is a summary of operations within geographic areas based on the customers location (in thousands):
Three Months Ended | Nine Months Ended | ||||||||||||||||
March 31, | March 31, | ||||||||||||||||
2003 | 2002 | 2003 | 2002 | ||||||||||||||
Revenue from sales
to unaffiliated
customers: |
|||||||||||||||||
Taiwan |
$ | 11,588 | $ | 19,968 | $ | 41,947 | $ | 59,154 | |||||||||
China |
8,296 | 523 | 16,112 | 1,614 | |||||||||||||
Other |
6,219 | 3,930 | 14,420 | 13,624 | |||||||||||||
$ | 26,103 | $ | 24,421 | $ | 72,479 | $ | 74,392 | ||||||||||
Major customer data as a percentage of total revenue:
Three Months Ended | Nine Months Ended | |||||||||||||||
March 31, | March 31, | |||||||||||||||
2003 | 2002 | 2003 | 2002 | |||||||||||||
Customer B |
12 | % | * | 11 | % | * | ||||||||||
Customer C |
* | 18 | % | * | 18 | % | ||||||||||
Customer D |
* | * | * | 16 | % |
Major customer data as a percentage of total accounts receivable:
March 31, | June 30, | |||||||
2003 | 2002 | |||||||
Customer A |
* | 14 | % | |||||
Customer B |
10 | % | 14 | % | ||||
Customer D |
12 | % | * | |||||
Customer E |
* | 11 | % |
* | Less than 10% |
9
10. Recent Accounting Pronouncements
In December 2002, the FASB issued SFAS No. 148, Accounting For Stock-Based Compensation -Transition and Disclosure, an amendment of FASB Statement No. 123. This Statement amends FASB Statement No. 123, Accounting For Stock-Based Compensation, to provide alternative methods of transition for a voluntary change to the fair value based method of accounting for stock-based employee compensation. In addition, this Statement amends the disclosure requirements of Statement No. 123 to require prominent disclosures in both annual and interim financial statements about the method of accounting for stock-based employee compensation and the effect of the method used on reported results. We have elected to continue to follow APB Opinion 25, Accounting for Stock Issued to Employees, and related interpretations in accounting for stock options. The disclosures required by Statement Nos. 123 and 148 are included in Note 1 of our Notes to our Condensed Consolidated Financial Statements.
In November 2002, the FASB issued Interpretation No. 45, Guarantors Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness to Others, an interpretation of FASB Statements No. 5, 57, and 107 and rescission of FASB Interpretation No. 34. This Interpretation elaborates on the disclosures to be made by a guarantor in its interim and annual financial statements about its obligations under guarantees issued. This Interpretation also clarifies that a guarantor is required to recognize, at inception of a guarantee, a liability for the fair value of the obligation undertaken. The initial recognition and measurement provisions of the Interpretation are applicable to guarantees issued or modified after December 31, 2002. As of May 8, 2003, our guarantees that were issued or modified after December 31, 2002 were not material. The disclosure requirements of Interpretation No. 45 are effective for interim and annual periods ending after December 15, 2002 and are applicable to our product warranty liability (see Note 7 to our Condensed Consolidated Financial Statements).
In January 2003, the FASB issued Interpretation No. 46, Consolidation Of Variable Interest Entities. This Interpretation requires that if a business enterprise has a controlling financial interest in a variable interest entity, the assets, liabilities, and results of activities of the variable interest entity should be included in the consolidated financial statements of the business enterprise. This Interpretation is effective immediately for all new variable interest entities created or acquired after January 31, 2003. For variable interest entities created or acquired prior to February 1, 2003, the provisions of this Interpretation must be applied for the first interim or annual period beginning after June 15, 2003. We currently do not have any financial interest in variable interest entities. The adoption of this Interpretation did not have a material impact on our results of operations or financial position.
10
ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Forward-Looking Statements and Factors That May Affect Results
You should read the following discussion and analysis in conjunction with our condensed consolidated financial statements and notes in Item 1 above and with our audited consolidated financial statements and notes for the year ended June 30, 2002, included in our Annual Report on Form 10-K.
In addition to the historical information contained herein, this report contains forward-looking statements, including those related to market penetration and market share gains in the notebook, iAppliance, and other electronic device markets, revenue from the notebook, iAppliance, and other electronic device markets, growth rates of these markets, average selling prices, product mix, cost improvement programs, gross margins, customer relationships, research and development expenses, selling, general, and administrative expenses, and liquidity and anticipated cash requirements, that involve risks and uncertainties that could cause actual results to differ materially.
We caution that these statements are qualified by various factors that may affect future results, including the following: changes in the market for our products and the success of our customers products, our success in moving products from the design phase into the manufacturing phase, warranty obligations related to product failures, the failure of key technologies to deliver commercially acceptable performance, our dependence on the notebook market, penetration into new markets, the absence of both long-term purchase and supply commitments, and our lengthy development and product acceptance cycles. This report should be read in conjunction with the Risk Factors discussed in our Annual Report on Form 10-K for the year ended June 30, 2002.
Overview
We are a leading worldwide developer and supplier of custom-designed user interface solutions that enable people to interact more easily and intuitively with a wide variety of electronic devices. We began shipping our proprietary TouchPad in fiscal 1996 and are now the worlds leading supplier of interface solutions to the notebook computer market. Our interface solutions include our TouchPad, TouchStyk, and the combination of both a touchpad and pointing stick for dual pointing applications. We estimate that over half of all notebooks shipped during calendar year 2002 contained our products. We believe our market share results from the combination of our customer focus, the strength of our intellectual property, and our engineering know-how, which allow us to design products that meet the demanding design specifications of original equipment manufacturers, or OEMs. More than 95% of our revenue is generated through sales of our interface solutions to the notebook computer market.
Our manufacturing operations are based on a variable cost model in which we outsource all of our production requirements, eliminating the need for significant capital expenditures and allowing us to minimize our investment in inventories. This approach requires us to work closely with our manufacturing subcontractors to ensure adequate production capacity to meet our volume requirements. We provide our manufacturing subcontractors with six-month rolling forecasts and issue purchase orders based on our anticipated requirements for the next 90 days. We do not have any long-term supply contracts with any of our manufacturing subcontractors. Currently, we primarily use one third-party manufacturer to provide our proprietary capacitive-based application specific integrated circuits, or ASICs, and in certain cases we also rely on a single source or a limited number of suppliers to provide other key components of our products. Our cost of revenue includes all costs associated with the production of our products, including materials, manufacturing, and assembly costs, paid to third-party manufacturers and related overhead costs associated with our manufacturing operations personnel. Additionally, all warranty costs and any inventory provisions or write-downs are expensed as cost of revenue.
Our gross margin generally reflects the combination of the added value we bring to our customers products in meeting their custom design requirements and our ongoing cost-improvement programs. In the future, we plan to introduce additional new products, which may initially negatively impact our gross margin, as was the case with the introduction of our initial dual pointing solutions in fiscal 2001.
Our research and development expenses include expenses related to product development, engineering, materials costs, patent expenses, and the costs incurred to design interface solutions for customers prior to the customers commitment to incorporate those solutions into their products. These expenses have generally increased,
11
reflecting our continuing commitment to the technological and design innovation required to maintain a leadership position in our existing markets and to develop new technologies for new markets.
Selling, general, and administrative expenses include expenses related to sales, marketing, and administrative personnel; internal sales and outside sales representatives commissions; market research and consulting; and other marketing and sales activities. Increased sales staffing and additional management personnel in anticipation of our continued growth in our existing markets and penetration into new markets have generally caused selling, general, and administrative expenses to increase.
In connection with the grant of stock options to our employees and consultants, we have recorded deferred stock compensation of approximately $3.0 million, representing the difference between the deemed fair value of our common stock for financial reporting purposes and the exercise price of these options at the date of grant. Deferred stock compensation is presented as a reduction of stockholders equity and is amortized on a straight-line basis over the vesting period. Options granted are typically subject to a four-year vesting period. Restricted stock acquired through the exercise of unvested stock options is subject to our right to repurchase the unvested stock at the price paid, with the right to repurchase lapsing over the vesting period. We are amortizing the deferred stock compensation over the vesting periods of the applicable options and the repurchase periods for the restricted stock. As of March 31, 2003, there was $1.3 million of deferred stock compensation remaining to be amortized in future periods.
Critical Accounting Policies and Estimates
The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosure of contingent assets and liabilities. We believe the following critical accounting policies affect our more significant judgments and estimates used in the preparation of our condensed consolidated financial statements. Actual results may differ from these estimates under different assumptions or conditions.
Revenue Recognition
We recognize revenue from product sales when there is persuasive evidence that an arrangement exists, delivery has occurred and title has transferred, the price is fixed and determinable, and collectibility is reasonably assured. We accrue for estimated sales returns and other allowances at the time of recognition of revenue, which is typically upon shipment, based on historical experience. Contract revenue for research and development is recorded as earned based on the performance requirements of the contract. Non-refundable contract fees for which no further performance obligations exist, and for which there is no continuing involvement by us, are recognized on the earlier of when the payments are received or when collection is assured.
Allowance for Doubtful Accounts
We maintain allowances for doubtful accounts for estimated losses resulting from the inability of customers to meet their financial obligations. On an ongoing basis, we evaluate the collectibility of accounts receivable based on a combination of factors. In circumstances in which we are aware of a specific customers inability to meet its financial obligation, we record a specific reserve. In addition, we must make judgments and estimates of the collectibility of accounts receivable based on historical bad debt, customers creditworthiness, current economic trends, recent changes in customer payment trends, and deterioration in the customers operating results or financial position. If circumstances change adversely, additional allowances may be required.
Inventory
We are required to state our inventories at the lower of cost or market. Our assessment of the ultimate realization of inventories is based on our projections of future demand and market conditions. Any sudden decline in demand or rapid product improvements and technological changes, or both, can cause us to have excess or obsolete inventories. On an ongoing basis, we review for estimated obsolete or unmarketable inventories and write down our inventories to their net realizable value based upon our forecasts of future demand and market conditions. If actual market conditions are less favorable than our forecasts, additional inventory reserves may be required. Our estimates are influenced by the following considerations: sudden decline in demand due to economic downturn or customer
12
demand, rapid product improvements and technological changes, and termination by our OEM customers of any product offerings incorporating our product solutions.
Warranty
We generally warrant our products for a period of 12 months from the date of sale and estimate probable product warranty costs at the time revenue is recognized. While we engage in extensive product quality programs and processes, including actively monitoring and evaluating the quality of our materials and service suppliers, our warranty costs are affected by product failure rates, material usage, and service delivery costs incurred in correcting a product failure. We exercise judgment in determining the estimates underlying our accrued warranty liability. The actual results with regard to warranty expenditures could have a material adverse effect on our operating results if the actual rate of unit failure is greater than what we used in estimating the accrued warranty liability.
Results of Operations
Three months ended March 31, 2003 compared to three months ended March 31, 2002
Net revenue was $26.1 million for the three months ended March 31, 2003 compared to $24.4 million for the three months ended March 31, 2002, an increase of 6.9%. The net increase in revenue was primarily attributable to increased unit shipments, partially offset by a reduction in overall average selling price, resulting from a change in product mix and general competitive pricing. During the three months ended March 31, 2003, sales of higher priced dual pointing products decreased to approximately 42% of our revenue from 45% for the three months ended March 31, 2002. Revenue contributions from non-PC applications and patent license fees also helped to partially offset the lower overall average selling price.
Gross margin as a percentage of revenue was 41.1% for the three months ended March 31, 2003 compared to 41.9% for the three months ended March 31, 2002. The reduction in gross margin as a percentage of revenue primarily reflected a lower average selling price resulting from general competitive pricing and a shift in mix to lower margin products, partially offset by lower manufacturing costs, which resulted from the combination of our ongoing design and process improvement programs and lower materials and assembly costs.
Research and development expenses increased 21.4% to $4.9 million, or 18.9% of revenue, for the three months ended March 31, 2003 from $4.1 million, or 16.7% of revenue, for the three months ended March 31, 2002. The major contributors to the increase in spending were costs associated with our higher staffing levels, including compensation and facilities-related costs, additional new product development activities, which included outside services and materials costs, and higher patent-related costs.
Selling, general, and administrative expenses increased 15.5% to $2.7 million, or 10.4% of revenue, for the three months ended March 31, 2003 from $2.4 million, or 9.6% of revenue, for the three months ended March 31, 2002. The increase in spending resulted mainly from higher compensation costs associated with increased staffing levels, higher commission expense on higher net revenue, and additional expenses related to generally higher operating levels.
Amortization of other intangible assets related to our October 1999 acquisition of Absolute Sensors Limited, or ASL, a company located in Cambridge, United Kingdom. As of December 31, 2002, these intangible assets were fully amortized. As a result, for the three months ended March 31, 2003, there was no amortization of other intangible assets compared to $29,000 for the three months ended March 31, 2002.
The three months ended March 31, 2003 included amortization expense for deferred stock compensation of $137,000 compared to $121,000 for the three months ended March 31, 2002. The increase in deferred stock compensation amortization expense was due to additional stock option grants to non-employees partially offset by forfeitures. We expect to record amortization expense for deferred stock compensation of $137,000 in the remaining three months of fiscal 2003 and the balance of $1.2 million in future years.
We generated operating income of $2.9 million for the three months ended March 31, 2003 compared to $3.7 million for the three months ended March 31, 2002. The major contributor to the decrease in operating income was the increase in operating expense, which primarily resulted from costs associated with our increased staffing levels,
13
including higher compensation and facilities-related costs, higher research and development costs related to increased product development activities, and increased commission expense from higher net revenue. Also contributing to lower operating income was the decrease in gross margin percentage, which was primarily caused by lower average selling price, resulting from general competitive pricing and a shift in mix to lower margin products. The increase in operating expenses and decrease in gross margin percentage was partially offset by higher revenue, resulting primarily from increased unit shipments.
Net interest income was $224,000 for the three months ended March 31, 2003 compared to $108,000 for the three months ended March 31, 2002, reflecting the benefit of higher average cash balances available for investment activities resulting primarily from the net proceeds of our initial public offering of 5.0 million shares at $11.00 per share, which closed on February 1, 2002.
The provision for income taxes for the three months ended March 31, 2003 was $1.1 million compared to $1.3 million for the three months ended March 31, 2002, a decrease of $242,000, reflecting the lower pre-tax profit levels and a lower effective tax rate of 34.3% for the three months ended March 31, 2003 compared to 35.1% for the three months ended March 31, 2002. The income tax provision represents the estimated federal and state taxes and the foreign taxes associated with our operations in the United Kingdom, Taiwan, and Japan. The difference between the federal statutory rate of 35% and our effective rate of 34.3% for the three months ended March 31, 2003 is primarily due to state taxes, expected research and development credits, and federal tax-exempt investments.
Nine months ended March 31, 2003 compared to nine months ended March 31, 2002
Net revenue was $72.5 million for the nine months ended March 31, 2003 compared to $74.4 million for the nine months ended March 31, 2002, a decrease of 2.6%. The decrease in revenue was primarily attributable to changes in product mix, general competitive pricing pressure, and lower non-recurring engineering and patent license fees, partially offset by increased unit shipments. During the nine months ended March 31, 2003, sales of higher priced dual pointing products decreased to approximately 42% of our revenue compared to 49% for the nine months ended March 31, 2002. Net revenue decreases caused by product mix changes and competitive pricing, resulting in a lower average selling price, were partially offset by increased unit shipments of touchpads as well as revenue contributions from non-PC applications.
Gross margin as a percentage of revenue was 42.4% for the nine months ended March 31, 2003 compared to 40.6% for the nine months ended March 31, 2002. The improvement in gross margin as a percentage of revenue primarily resulted from our cost reduction programs, which included manufacturing efficiencies gained from design and process improvements and lower materials and assembly costs, partially offset by a decrease in mix of higher margin products, lower selling prices resulting from general competitive pricing, and lower non-recurring engineering and patent license revenue.
Research and development expenses increased 26.9% to $15.1 million, or 20.8% of revenue, for the nine months ended March 31, 2003 from $11.9 million, or 16.0% of revenue, for the nine months ended March 31, 2002. The major contributors to the increased spending were costs associated with our higher staffing levels, including compensation and facilities-related costs, higher product development activities, which included outside services and materials costs, and higher patent-related costs.
Selling, general, and administrative expenses increased 6.8% to $8.0 million, or 11.0% of revenue, for the nine months ended March 31, 2003 from $7.5 million, or 10.0% of revenue, for the nine months ended March 31, 2002. The increase in spending resulted mainly from higher compensation costs associated with increased staffing levels, higher expenses related to generally higher operating levels, and additional costs related to our status as a public reporting company, partially offset by lower sales commissions, primarily resulting from the replacement of outside sales representatives with inside sales personnel for certain customer accounts that we implemented in October 2001, and to a lesser extent, the decrease in revenue.
Amortization of other intangible assets related to our October 1999 acquisition of ASL. As of December 31, 2002, these intangible assets were fully amortized. For the nine months ended March 31, 2003, the amount amortized was $40,000 compared to $104,000 for the nine months ended March 31, 2002.
14
The nine months ended March 31, 2003 and March 31, 2002 included amortization expense for deferred stock compensation of $363,000 for both periods. We expect to record amortization expense for deferred stock compensation of $137,000 in the remaining three months of fiscal 2003 and the balance of $1.2 million in future years.
We generated operating income of $7.3 million for the nine months ended March 31, 2003 compared to $10.4 million for the nine months ended March 31, 2002. The major contributors to the lower operating income were the increase in operating expenses, which primarily resulted from higher costs associated with our increased staffing levels, including higher compensation and facilities-related costs, higher research and development costs related to increased product development activities, and additional costs related to our status as a public reporting company, and the decrease in revenue, primarily reflecting the impact of a lower mix of higher margin products, lower average selling prices, and lower revenues from non-recurring engineering and patent license fees. The increase in operating expenses and the decrease in revenue were partially offset by an improvement in gross margin percentage, resulting from lower manufacturing costs related to improved manufacturing efficiencies from our ongoing design and process improvement programs and lower materials and assembly costs, increased unit shipments, and lower sales commissions.
Net interest income was $694,000 for the nine months ended March 31, 2003 compared to $76,000 for the nine months ended March 31, 2002, primarily reflecting the benefit of higher cash balances available for investment activities from the net proceeds of our initial public offering of 5.0 million shares at $11.00 per share, which closed on February 1, 2002.
The provision for income taxes for the nine months ended March 31, 2003 was $2.9 million compared to $3.7 million for the nine months ended March 31, 2002, reflecting the lower pre-tax profit levels, partially offset by a higher effective tax rate of 36% for the nine months ended March 31, 2003 compared to 35% for the nine months ended March 31, 2002. The income tax provision represents the estimated federal and state taxes and the foreign taxes associated with our operations in the United Kingdom, Taiwan, and Japan. The difference between the federal statutory rate of 35% and our effective rate of 36% for the nine months ended March 31, 2003 is primarily due to state taxes, expected research and development credits, and federal tax-exempt investments.
Liquidity and Capital Resources
Our cash, cash equivalents, and short-term investments were $72.9 million as of March 31, 2003 compared to $65.2 million as of June 30, 2002, an increase of $7.7 million. During the nine months ended March 31, 2003, cash and cash equivalents decreased by $6.9 million, while short-term investments increased by $14.6 million. The primary factors contributing to the changes in cash, cash equivalents, and short-term investments are described below.
During the nine months ended March 31, 2003, operating activities generated cash of $7.2 million compared to $9.5 million during the nine months ended March 31, 2002. For the nine months ended March 31, 2003, the increase in cash was mainly attributable to net income, adjusted for depreciation and amortization of acquired intangible assets and deferred stock compensation, of $6.6 million and a net change in operating assets and liabilities of $555,000. For the nine months ended March 31, 2002, net income, adjusted for depreciation and amortization, contributed $8.2 million, while a net change in operating assets and liabilities contributed an additional $1.3 million.
Our investing activities typically relate to purchases of government-backed securities and investment-grade fixed income instruments and capital assets. Investing activities during the nine months ended March 31, 2003 used cash of $15.5 million compared to $7.8 during the nine months ended March 31, 2002. Cash used during the nine months ended March 31, 2003 consisted of purchases of $18.1 million of short-term investments and $898,000 of capital equipment, partially offset by cash generated from sales and maturities of short-term investments of $3.6 million. Cash used for investments during the nine months ended March 31, 2002 consisted of the purchases of short-term investments of $6.7 million and capital equipment of $1.1 million.
Net cash provided by financing activities for the nine months ended March 31, 2003 was $1.4 million compared to $50.1 million during the nine months ended March 31, 2002. For the nine months ended March 31, 2003, financing activities primarily related to proceeds from common stock issued under our Employee Stock Purchase Plan and stock option plans, and repayment of notes receivable from stockholders, less payments made on capital lease and equipment financing obligations. For the nine months ended March 31, 2002, in addition to the above activities we generated net proceeds of $49.3 million from the issuance of 5.0 million shares of our common stock at $11.00 per share related to our initial public offering, which closed on February 1, 2002.
15
Our principal sources of liquidity as of March 31, 2003 consisted of $72.9 million in cash, cash equivalents, and short-term investments and a $4.2 million working capital line of credit with Silicon Valley Bank. The Silicon Valley Bank revolving line of credit expires on November 25, 2003, has an interest rate equal to Silicon Valley Banks prime lending rate, and provides for a security interest in substantially all of our assets. We had not borrowed any amounts under the line of credit as of March 31, 2003. The long-term note payable to National Semiconductor represents limited-recourse debt that is secured solely by a portion of our stockholdings in Foveon, Inc., in which National Semiconductor is also an investor. We do not anticipate making any payments under the limited-recourse loan with National Semiconductor, either prior to or at maturity, unless Foveon is participating in a liquidity event, such as an initial public offering of its equity securities or a merger, through which we would be able to receive amounts in excess of our $1.5 million long-term note payable plus accrued interest expense.
We believe our existing cash, cash equivalents, and short-term investments will be sufficient to meet our cash requirements at least through the next 12 months. Our future capital requirements will depend on many factors, including our rate of revenue growth, our operating performance, our ability to maintain our gross margin as a percentage of revenue, the timing and extent of spending to support product development efforts, the expansion of sales and marketing activities, the timing of introductions of new products and enhancements to existing products, the costs to ensure access to adequate manufacturing capacity, the continuing market acceptance of our product solutions, and the amount and timing of our investment in, or acquisition of, other technologies or companies. We cannot assure you that additional equity or debt financing, if needed, will be available to us on acceptable terms or at all.
The following table provides a summary of the effect on cash flows from our contractual obligations as of March 31, 2003:
Payments Due by Fiscal Year (in thousands) | ||||||||||||||||||||
Contractual | 2004 to | 2006 to | 2008 and | |||||||||||||||||
Cash Obligations | 2003 | 2005 | 2007 | thereafter | Total | |||||||||||||||
Note payable and
interest |
$ | | $ | | $ | 2,686 | $ | | $ | 2,686 | ||||||||||
Operating leases |
252 | 1,931 | 506 | | 2,689 | |||||||||||||||
Capital leases |
86 | 266 | | | 352 | |||||||||||||||
Total |
$ | 338 | $ | 2,197 | $ | 3,192 | $ | | $ | 5,727 | ||||||||||
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Market risk for our company has not changed significantly from the interest rate and foreign currency risks disclosed in Item 7A of our Annual Report on Form 10-K for the fiscal year ended June 30, 2002.
ITEM 4. CONTROLS AND PROCEDURES
Within 90 days prior to the date of the filing of this report, our Chief Executive Officer and Chief Financial Officer have reviewed and evaluated the effectiveness of our disclosure controls and procedures, which included inquires made to certain other of our employees. Based on their evaluation, our Chief Executive Officer and Chief Financial Officer have each concluded that our disclosure controls and procedures are effective and sufficient to ensure that we record, process, summarize, and report information required to be disclosed by us in our periodic reports filed under the Securities Exchange Act within the time periods specified by the Securities and Exchange Commissions rules and forms.
There have been no significant changes in our internal controls or in other factors that could significantly affect these controls, including any corrective actions with regard to significant deficiencies and material weaknesses, subsequent to the date of evaluation described above.
16
PART II OTHER INFORMATION
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
(a) | Exhibits: |
99.1 | Certification of the Chief Executive Officer of the Registrant, pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |||||
99.2 | Certification of the Chief Financial Officer of the Registrant, pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
(b) | Reports on Form 8-K: |
On March 31, 2003 we filed a Report on Form 8-K, under Item 4, to disclose a change in certifying accountant.
17
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
SYNAPTICS INCORPORATED | ||
Date: May 8, 2003 |
/s/ Francis F. Lee Francis F. Lee President and Chief Executive Officer |
|
/s/ Russell J. Knittel Russell J. Knittel Senior Vice President and Chief Financial Officer |
18
CERTIFICATIONS
I, Francis F. Lee, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Synaptics Incorporated;
2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;
3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;
4. The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:
a) Designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared; |
b) Evaluated the effectiveness of the registrants disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the Evaluation Date); and |
c) Presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date; |
5. The registrants other certifying officers and I have disclosed, based on our most recent evaluation, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent function):
a) All significant deficiencies in the design or operation of internal controls which could adversely affect the registrants ability to record, process, summarize and report financial data and have identified for the registrants auditors any material weaknesses in internal controls; and |
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls; and |
6. The registrants other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.
Date: May 8, 2003 | ||
/s/ Francis F. Lee Francis F. Lee President and Chief Executive Officer |
19
I, Russell J. Knittel, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Synaptics Incorporated;
2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;
3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;
4. The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:
a) Designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared; |
b) Evaluated the effectiveness of the registrants disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the Evaluation Date); and |
c) Presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date; |
5. The registrants other certifying officers and I have disclosed, based on our most recent evaluation, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent function):
a) All significant deficiencies in the design or operation of internal controls which could adversely affect the registrants ability to record, process, summarize and report financial data and have identified for the registrants auditors any material weaknesses in internal controls; and |
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls; and |
6. The registrants other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.
Date: May 8, 2003 | ||
/s/ Russell J. Knittel Russell J. Knittel Senior Vice President, Chief Financial Officer, Chief Administrative Officer, Secretary, and Treasurer |
20
EXHIBIT INDEX
EXHIBIT | ||||||
NUMBER | DESCRIPTION | |||||
99.1 | Certification of the Chief Executive Officer of the Registrant, pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |||||
99.2 | Certification of the Chief Financial Officer of the Registrant, pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |